RIVASTIGMINE

RIVASTIGMINE: Rivastigmine is a medication commonly prescribed for the treatment of mild to moderate dementia symptoms associated with Alzheimer’s disease and Parkinson’s disease. It is sold under the brand name Exelon.

The primary use of rivastigmine is to improve cognitive function in patients with dementia. It belongs to a class of drugs called cholinesterase inhibitors, which work by increasing the levels of a neurotransmitter called acetylcholine in the brain. Acetylcholine is involved in the processes of memory, attention, and thinking, and its deficiency is thought to contribute to the symptoms of dementia.

The initial recommended dose of rivastigmine is usually 1.5 mg, taken orally twice a day with meals. The dose may be gradually increased every two weeks, as tolerated, up to a maximum daily dose of 6 mg (exelon capsule) or 9.5 mg (exelon patch). The medication can be taken with or without food, but it is generally recommended to take it with meals to reduce the risk of gastrointestinal side effects.

Common side effects of rivastigmine include nausea, vomiting, diarrhea, loss of appetite, weight loss, dizziness, headache, and excessive sweating. These side effects are often mild and transient, but if they persist or worsen, it is advised to consult a healthcare professional. Additionally, some patients may experience more serious side effects such as severe gastrointestinal problems (e.g., stomach ulcers, bleeding) or allergic reactions. It is important to inform a healthcare professional about any unusual or concerning side effects.

Overall, rivastigmine works to alleviate cognitive symptoms associated with dementia by increasing acetylcholine levels in the brain. It should, however, be noted that rivastigmine is not a cure for dementia and may only provide temporary improvement in symptoms. Regular monitoring by a healthcare professional is necessary to assess the drug’s effectiveness and adjust the dosage as needed.